Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
429 results
  1. pdf2017MeshTreesWithChangesShown.pdf 
    https://www.nlm.nih.gov/.../2017MeshTreesWithChangesShown.pdf
    ... Factor Receptor alpha Receptors, Thrombopoietin Receptors, Transforming Growth Factor beta Receptors, Tumor Necrosis Factor Antigens, CD27 Antigens, CD30 Antigens, CD40 Antigens, ...
  2. pdf2018MeShTreeHierarchy.pdf 
    https://www.nlm.nih.gov/mesh/2018/download/2018MeShTreeHierarchy.pdf
    ... Inhibitory Factors D12.644.276.374.480.438...........................................Lymphotoxin-alpha D12.644.276.374.480.615...........................................Macrophage-Activating ...
  3. pdf2016MeshTree.pdf 
    https://www.nlm.nih.gov/mesh/2016/download/2016MeshTree.pdf
    ... Inhibitory Factors D12.644.276.374.480.438...........................................Lymphotoxin-alpha D12.644.276.374.480.615...........................................Macrophage-Activating ...
  4. Osteosarcoma and Malignant Fibrous Histiocytoma of Bone Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI ... 
    https://www.ncbi.nlm.nih.gov/books/NBK65736
    ... syndrome; RANKL = receptor activator of nuclear factor kappa beta ligand; TNF = tumor necrosis factor. a Adapted from Kansara et al.[ 78 ] Refer ... same EURAMOS trial, patients with less than 90% necrosis were randomly assigned to ... factor kappa beta ligand (RANKL) antibody, in patients with recurrent osteosarcoma, ...
  5. NLM Digital Collections - Economic analysis of availability of follow-on protein products : final report 
    Publication: [Washington, DC] : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, 2009
    resource.nlm.nih.gov/101615134
    ... including:  Erythropoietin (EPO)  Cancer monoclonal antibodies (MAbs)  Anti-tumor necrosis factor (anti-TNF) agents  Interferon beta  Granulocyte-colony stimulating factor (G-CSF)  Interferon alpha ...
  6. Mistletoe Extracts (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66054
    ... K, Frei K, et al.: Increased secretion of tumor necrosis factors alpha, interleukin 1, and interleukin 6 by human mononuclear cells exposed to beta-galactoside-specific lectin from clinically applied mistletoe extract. ...
  7. pdf213-224-1987.pdf 
    https://www.nlm.nih.gov/.../nlmarchives/techbull/213-224-1987.pdf
    ... Submenu Therapies are: 1 Alpha interferon therapy 2 Beta interferon therapy 3 Gamma interferon therapy 4 Tumor necrosis factor therapy 5 LAR/Interleukin-2 therapy 6 Monoclonal ...
  8. pdf2017NewMeshHeadingsSingleColumnWithScopeAnTree.pdf 
    https://www.nlm.nih.gov/...shHeadingsSingleColumnWithScopeAnTree.pdf
    ... protein. It cleaves the membrane-bound precursor of TUMOR NECROSIS FACTOR-ALPHA between ALANINE 76 and VALINE 77 to its functional form, as well as several other CELL SURFACE PROTEINS to their soluble forms, including AMYLOID BETA-PROTEIN PRECURSOR and PRION PROTEIN. Tree locations: ADAM ...
  9. NLM Digital Collections - Annual report - National Eye Institute (1992) 
    Publication: [Bethesda, Md.] : National Eye Institute
    resource.nlm.nih.gov/7802080X19
    ... Human RPE cultures exposed to bacterial lipopolysaccharide (LPS), tumor necrosis factor alpha (TNF-a), and interleukin 1 alpha and beta (IL-la and IL-lp) secreted large amounts ...
  10. NLM Digital Collections - Annual report - National Eye Institute (1993) 
    Publication: [Bethesda, Md.] : National Eye Institute
    resource.nlm.nih.gov/7802080X20
    ... Human RPE cultures exposed to bacterial lipopolysaccharide (LPS), tumor necrosis factor alpha (TNF-a), and interleukins 1 alpha and 1 beta (IL-loc, IL-lp) secreted large amounts of ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · next · last